Frontlight ResearchEarly access
Trial site
Affiliated Hospital of Yangzhou University
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Stroke2 trials
- COPD1 trial
- Coronary artery disease1 trial
- Lewy body dementia1 trial
- Multiple system atrophy1 trial
- Rheumatoid arthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 23 trials
- Phase 32 trials
- Phase 42 trials
- Status
- Recruiting3 trials
- Completed2 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Enrolling by invitation1 trial
- Lead sponsor
- Bayer1 trial
- Janssen Research & Development, LLC1 trial
- Mabwell (Shanghai) Bioscience Co., Ltd.1 trial
- Nanjing First Hospital, Nanjing Medical University1 trial
- Peking Union Medical College Hospital1 trial
- and 4 more
Running trials
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Refractory Rheumatoid Arthritis
Recruiting
Multi-Center Study of Natural History in Atypical Parkinsonian Syndromes (MAPS-NH)
Recruiting
A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Recruiting
Efficacy and Safety of Telitacicept in the Treatment of Systemic Sclerosis
Enrolling by invitation
Multicenter Prospective Cohort Study of Hypertriglyceridemia Acute Pancreatitis
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- COPD1 recruiting
- Coronary artery disease1 recruiting
- Lewy body dementia1 recruiting
- Multiple system atrophy1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026